French tire maker Michelin said on Thursday it would close down a site in the town of La Roche-sur-Yon, which has 619 staff, as the auto industry grapples with tough market conditions.
China has urged the United States to stop unreasonable pressure on Chinese companies, including Huawei Technologies, foreign ministry spokesman Geng Shuang said at a daily press briefing on Thursday.
Oil prices eased on Thursday on the expectations that the resumption of U.S.-China talks will not end the trade war between the world’s two largest oil consumers, exacerbating anxiety over the global economy and fuel demand.
The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make… …read more […]
Shares in LVMH rose on Thursday, lifting up other European luxury goods stocks, after the Louis Vuitton owner posted higher-than-expected third quarter sales.
(Bloomberg) — The unprecedented power shutdown by California’s PG&E Corp. has spread deeper into densely populated cities near San Francisco, ensnaring millions of people and raising the prospect that much of a major metropolitan area could go without electricity for days.The bankrupt utility said late Wednesday that it had begun a second round of power cuts that will plunge another 234,000 customers in cities including Berkeley and Oakland into darkness. It’s part of the biggest blackout ever orchestrated to prevent strong winds from knocking down electrical lines and igniting fires. Half a million homes and businesses in Northern California were …read more […]
Today we’ll look at MTU Aero Engines AG (ETR:MTX) and reflect on its potential as an investment. Specifically, we’re… …read more […]
Philips said on Thursday trade tariffs and poor results at its Connected Care arm meant the Dutch healthcare technology firm would miss its 2019 target for profit margin improvement. Although Philips now expects adjusted EBITA margin to improve by 10 to 20 basis points, well off its previous 100 basis point goal, it said in a statement it was sticking to its 2020 target of improving comparable sales by 4% to 6%. “We continue to see good growth momentum across our businesses,” Chief Executive Frans van Houten said, adding he was disappointed by a margin decline in …read more […]
General Motors Co’s July to September vehicle sales in China fell 17.5%, as the U.S. automaker was hurt by a slowing economy amid the Sino-U.S. trade war and by heightened competition in its key mid-priced SUV segment.
Strengthening the alliance between car makers Renault and Nissan is crucial, said French junior economy minister Agnes Pannier-Runacher on Thursday, amid signs of a possible management shake-up at Renault.
U.S. and Chinese negotiators meet in Washington on Thursday and Friday to try, once again, to defuse a trade war that has roiled markets and triggered tit-for-tat tariffs on hundreds of billions of goods traded between the world’s largest economies.
The United States’ and China’s top trade negotiators were set to meet on Thursday for the first time since late July to try to find a way out of a 15-month trade war as new irritants between the world’s two largest economies threatened hopes for progress.
Facebook’s Libra may be grabbing all the headlines at the moment, yet a major cryptocurrency already exists that’s gained a toehold in mainstream commerce.
Japanese stocks bounced back from early losses to end higher on Thursday, helped by a flush of optimism over chances that the United States and China can scale back their trade war at high-level talks set for later in the day. The Nikkei index ended up 0.45% at 21,551.98, after shedding as much as 0.7% earlier in the day. Japanese shares were boosted by a New York Times report that U.S. President Donald Trump’s administration will soon issue licences allowing some U.S. companies to supply non-sensitive goods to Chinese telecommunications equipment maker Huawei Technologies Co Ltd. …read more […]
UCB has agreed to acquire U.S.-based Ra Pharmaceuticals for $2.1 billion, both companies reported on Thursday, in a deal that will enable the Belgian drugmaker to offer new treatment opportunities for several rare diseases in neurology and immunology. “Ra Pharma is an excellent strategic fit addressing multiple areas of UCB’s patient value growth strategy,” UCB’s Chief Executive Officer Jean-Christophe Tellier said in a joint statement. The acquisition of the clinical-stage biopharmaceutical company, which was founded in 2008, is expected to contribute to UCB’s core earning per share and increase its revenue and net profit from 2024 onwards. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
